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Abstract
Background: Over the last decade, patient involvement in treatment-related decision-making has
been widely advocated in Japan, where patient-physician encounters are still under the influence of
the long-standing tradition of paternalism. Despite this profound change in clinical practice, studies
investigating the actual preferences of Japanese people regarding involvement in treatment-related
decision-making are limited. The main objectives of this study were to (1) reveal the actual level of
involvement of Japanese cancer patients in the treatment-related decision-making and their overall
satisfaction with the decision-making process, and (2) consider the practical implications of
increased satisfaction in cancer patients with regard to the decision-making process.
Methods: We conducted semi-structured interviews with 24 Japanese cancer patients who were
recruited from a cancer self-help group in Tokyo. The interviews were qualitatively analysed using
the approach described by Lofland and Lofland.
Results: The analyses of the patients' interviews focused on 2 aspects: (1) who made treatment-
related decisions (the physician or the patient), and (2) the informants' overall satisfaction with the
decision-making process. The analyses revealed the following 5 categories of decision-making:
'patient as the active decision maker', 'doctor selection', 'wilfully entrusting the physician',
'compelled decision-making', and 'surrendering decision-making'. While the informants under the
first 3 categories were fairly satisfied with the decision-making process, those under the latter 2
were extremely dissatisfied. Informants' views regarding their preferred role in the decision-making
process varied substantially from complete physician control to complete patient control; the key
factor for their satisfaction was the relation between their preferred involvement in decision-
making and their actual level of involvement, irrespective of who the decision maker was.
Conclusion:  In order to increase patient satisfaction with regard to the treatment-related
decision-making process, healthcare professionals in Japan must assess individual patient
preferences and provide healthcare accordingly. Moreover, a better environment should be
created in hospitals and in society to facilitate patients in expressing their preferences and
appropriate resources need to be made available to facilitate their decision-making process.
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Background
Over the last two decades, patient participation in treat-
ment-related decision-making has been promoted as
being ethically and clinically desirable in Western coun-
tries [1-3]. Several studies have indicated that patient par-
ticipation in decision-making has a positive influence on
their health outcomes, thereby increasing patient satisfac-
tion regarding medical care and promoting patient auton-
omy [4-6].
Charles and colleagues provided useful suggestions for
developing a framework for the analysis of treatment-
related decision-making and proposed 3 analytical
approaches that have been reported in the recent history
of developed countries: the paternalistic approach, char-
acterised by physician control; the informed approach,
characterised by division of labour and preservation of
patient autonomy; and the shared approach, characterised
by simultaneous interaction between both the patient and
physician in all stages of the decision-making process [7].
Further, they suggested that decision-making is not merely
the act of 'making a decision'; in fact, it is an interactive
process between a patient and her/his physician. The
process consists of 3 analytically distinct steps based on
which the 3 approaches (paternalistic, informed, and
shared) can be compared and differentiated. The 3 steps
are (1) exchange of information, (2) deliberation regard-
ing treatment options, and (3) decision-making related to
the treatment to be implemented [8]. They argue that the
third step is an outcome of the deliberation process.
Despite the fact that patient involvement in treatment-
related decision-making has been widely advocated and
promoted in both clinical and policy-making settings in
many developed countries, research conducted in the US,
Canada, and the UK revealed that people's preferences
regarding their role in the decision-making process vary
substantially [9-15]. Some research further indicated that
the preference for handing over the control to the physi-
cian is significantly greater when the situation involves
potential mortality or when the respondents' health status
is deteriorating [9-11,15]. Moreover, other studies have
revealed that the relationship between patient preferences
regarding their involvement in the decision-making proc-
ess and their actual level of involvement is a strong indi-
cator of patient satisfaction [12,14]. Thus, it has been
increasingly emphasised that (1) healthcare professionals
need to assess individual patient preferences in order to
provide tailor-made care accordingly [14,15] and (2)
merely pressurising patients to decide a treatment option
could have negative psychosocial consequences, if the
patient does not wish to be the final decision maker [14].
Japan has had a long-standing tradition of paternalism
with regard to patient-physician encounter. Nomura and
colleagues [16] described the dominant category regard-
ing the patient-physician relationship in Japan as follows:
'the relationship between a [Japanese] physician and a
patient is clearly asymmetrical, since the patient seeks
help and care from a medical expert whose diagnostic
evaluations are more or less indisputable and whose deci-
sions have to be accepted by the patient without discus-
sion'. This type of a traditional decision-making process in
which the patient leaves the decision to her/his physician
has been described by researchers and termed in Japanese
as the 'Omakase (entrusting)' style [17,18]. The Omakase
style of decision-making can be encountered in many sce-
narios of everyday life in Japan where the experience,
knowledge, and advice of experts is highly respected.
However, the need to recast the traditional paternalistic
patient-physician relationship has become sufficiently
pervasive, and the relationship is, therefore, undergoing a
gradual transformation [19,20]. In 2004, Japan Medical
Association (JMA), the largest medical professional body
in Japan, issued the Professional Ethics Guideline for Phy-
sicians [21] that provides a detailed explanation of the
professional code issued by the JMA in 2000 and stipu-
lates that physicians have an ethical obligation to disclose
in entirety all relevant information to the patient in a
comprehensible manner. Although the Guideline also
provides physicians the freedom to withhold information
if deemed 'appropriate' [22], it declares the basic stand-
point of the JMA which is to strongly endorse the principle
of information disclosure and obtain informed consent
from patients.
Over the years, clinical practice in Japan has witnessed
considerable changes with regard to the patient-physician
relationship. Although respecting patient autonomy is
regarded as important from various aspects of a patient-
physician encounter, there is a paucity of studies investi-
gating the actual preferences regarding the involvement of
Japanese people, who have been under the influence of
the Omakase culture for a long time, in treatment-related
decision-making. Some studies suggest that the prefer-
ences of Japanese patients, as well, regarding participation
in the decision-making process vary substantially.
Research involving Japanese hypertensive outpatients
using the Autonomy Preference Index has suggested that
patients had an intermediate desire to be involved in deci-
sion-making and a greater desire for information [16].
Another research on diabetic outpatients randomly
assigned 1 out of 3 case study vignettes (pneumonia, gan-
grene, or cancer) to patients and enquired about their atti-
tudes towards participation in the decision-making
process [23]. The overall percentage of respondents who
preferred active, collaborative, and passive roles was 12%,
71%, and 17%, respectively, respondents to the cancer
vignette being less likely to prefer an active role as com-
pared to the non-cancer vignette respondents. These stud-BMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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ies, however, investigated patient preferences under
hypothetical situations and did not include patient satis-
faction as an outcome.
Research investigating patient preferences in the decision-
making process in the context of cancer is even scarcer. It
deserves more attention because cancer affects a majority
of Japanese people, being the primary cause of death [24]
and the estimated lifetime prevalence being as high as
46.3% for men and 34.8% for women [25]. Further,
under the trend of information disclosure and promoting
informed consent in Japan over the last decade, Japanese
physicians have drastically shifted their attitudes towards
disclosing cancer diagnosis, which, earlier, used to be
undisclosed to patients [26-28]. For example, one
research that reviewed the medical and nursing charts of a
hospital suggested that the percentage of patients to
whom cancer diagnosis was disclosed increased from 27%
in 1993 to 71% in 1998 [28]. Japanese physicians should
now begin discussing treatment options, including the
risks and benefits, with their patients in an open aware-
ness context [29]; however, not all physicians are well
equipped for this since they lack adequate communica-
tion skills.
Given the above-mentioned backdrop, we decided to
investigate the current situation of treatment-related deci-
sion-making in the oncology setting in Japan. In this pre-
liminary research, we hoped to enquire from Japanese
cancer patients about their own experiences, not hypo-
thetical situations, regarding the decision-making process.
The main objectives of this study were to (1) reveal the
actual level of involvement of Japanese cancer patients in
treatment-related decision making and their overall satis-
faction with the decision-making process, and (2) con-
sider its practical implications in order to increase the
cancer patients' satisfaction with the decision-making
process.
Methods
Due to the paucity of researches on treatment-related deci-
sion-making in Japanese cancer patients, we decided to
conduct qualitative, semi-structured interviews in order to
obtain detailed descriptions of the variations in the expe-
riences of the informants with regard to their participation
in the decision-making process.
Recruitment of interview respondents
The informants were recruited from a cancer self-help
group in Tokyo. The group, which was established 20
years ago by a man with hepatoma, consists of 430 cancer
survivors who reside in the Tokyo metropolitan area. The
group does not limit itself to members of a particular age,
gender, or cancer site and operates on a membership fee
of ¥5000 (approximately US$47.00) per year. Occasion-
ally, healthcare providers participate as supporters, pro-
viding medical information; however, they do not take
any initiative in the administration of the group. We
decided to contact this particular group because we
wished to maximise the informants' demographic and
clinical backgrounds in order to explore a wide range of
patient-physician encounters in the context of treatment-
related decision-making among cancer patients in Japan.
Moreover, the fact that all the members of this group were
well informed about their cancer diagnosis made it opti-
mal for exploring their experiences in an open awareness
context.
Two authors (YW and MT) attended the monthly meet-
ings of the self-help group in 2001 and explained verbally
as well as in the form of flyers the purpose and procedures
of the research and its ethical considerations. Further, we
emphasised that we would prefer to recruit informants
from various backgrounds. Regarding the ethical consid-
erations, the ethical regulations in Japan as of 2001 did
not require this study to be submitted for scrutiny by the
ethical review committee. Nevertheless, we employed a
number of ethical considerations while undertaking the
research, including voluntary participation of the
respondents, their right to withdraw from the study at any
point of time, and the assurance that the data would not
be used for other purposes and all information would be
kept strictly confidential, and explained them to the par-
ticipants. Participants who chose to be involved in the
research were instructed to contact the principal author,
and a convenient time and place to conduct the interview
was negotiated.
Data collection
After obtaining informed consent, semi-structured inter-
views were conducted by the principal author, who is a
registered nurse with clinical experience in the oncology
setting. Interviews were conducted at a place chosen by
the respondents themselves, in order to protect their pri-
vacy and create a comfortable atmosphere for discussion;
these places included informants' homes, community
centres, coffee shops, and hospital waiting areas. The
informants were awarded a book coupon worth ¥1000
(approximately US$9.00) for their participation. With the
participants' permission, all interviews except one were
tape-recorded. For the informant who declined the use of
a tape recorder, the interviewer made notes by writing
down the informant's responses as accurately as possible;
these notes were used as supplementary data for the anal-
ysis. On average, the interviews lasted for a duration of 80
minutes, ranging between 55 and 200 minutes, and a total
of 35 hours of interview data was collected.
The interviews began with questions regarding the
informant's socio-demographic and clinical backgroundsBMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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followed by the treatment-related information provided
by her/his physician, the process of interaction with the
physician until the treatment plan was decided, and the
overall satisfaction with the treatment-related decision-
making process. Further, we enquired about the inform-
ants' experiences in decision-making regarding the critical
treatment modalities that might have considerably
affected the course of their disease, such as surgeries, radi-
ation therapy, and chemotherapy. As the interview data
accumulated, we attempted to include more questions in
order to delineate the similarities and differences among
informants who adopted different styles of participation
in the decision-making process. For example, to compare
the informants who attempted to actively make decisions
with those who left the decisions to the physicians, we
enquired about the reasons why they did so as well as the
factors that they considered important in making that par-
ticular decision. Immediately after each interview, the
interviewer (YW) wrote field notes regarding the impres-
sion of the interview.
Apart from conducting interviews, the principal author
participated in the regular monthly meetings of the group
over a period of 10 months in order to acquire an under-
standing of the background issues experienced by the
group members. The field notes obtained during the
observation were used as supplementary data while ana-
lysing the interviews.
Data analysis
Data analysis was conducted concurrently with the inter-
view process according to the procedures described by
Lofland and Lofland [30]. All the interviews that were
recorded on tape were transcribed verbatim. Subse-
quently, we repeatedly read the transcripts line by line and
placed conceptual labels accordingly. Many informants
experienced more than one opportunity to make a deci-
sion, and we assumed that the patients' decision-making
style might have varied under different circumstances;
therefore, the unit of the analysis was each opportunity to
make a decision rather than the informant herself/him-
self. Multiple conceptual labels were compared according
to their similarities and differences and were grouped
together to form loosely defined categories. Thereafter, the
preliminary categories created by the principal author
were scrutinised by the other authors to verify whether the
categories appropriately explained the variations in the
decision-making styles. MT is a physician researcher with
clinical experience in the oncology setting and expertise in
qualitative research methodology. IK is also a physician
researcher who is well versed with quality-of-life issues
and patient-physician relationships in Japan. First, we cat-
egorized each decision-making opportunity according to
the level of patient involvement, which was based on who
was the final decision maker in each decision-making
opportunity. However, we soon realised that the level of
patient satisfaction with the overall decision-making
process was not necessarily related to who made the final
decision – the patient or the physician. Therefore, we
compared each opportunity of decision-making based on
2 criteria: the final decision maker and the informants'
overall satisfaction. To ensure the validity of the analysis,
we sent its final version to 2 of the informants (informant
D and Q) for the purpose of member checking [31]. These
2 informants were selected because they were the core
members of the self-help group and could be consulted by
other group members regarding problems in patient-phy-
sician encounters. Based on their feedback, it can be stated
that the authors' interpretations adequately explained the
informants' experiences.
Results
A total of 24 interviews were conducted with 10 men and
14 women. The background information of the inform-
ants is presented in Table 1. The mean age of the inform-
ants was 57.8 years (range, 36–78 years) and the median
duration from diagnosis to interview was 5 years (range, 6
months-17 years). The primary cancer sites were the
lungs, esophagus, breasts, pancreas, liver, stomach,
uterus, colon, prostate, cartilaginous tissue, and lymph
nodes. Of the total informants, 2 had cancer involving
multiple sites, and 6 had cancer recurrence.
During the course of the analysis that focused on the final
decision maker and the informants' overall satisfaction,
the following 5 categories of decision-making emerged:
patient as the active decision maker, doctor selection, wil-
fully entrusting the physician, compelled decision-mak-
ing, and surrendering decision making (Figure 1). A
detailed description of each category has been provided
below.
Patient as the active decision maker
In this category, informants described themselves as active
participants in the decision-making process and recalled
the process with a high level of satisfaction. The inform-
ants in this category had their own opinions, beliefs, and
values with regard to their treatment.
I have my own philosophy that physicians simply treat dis-
eases, and merely following their advice does not necessarily
save patients' lives. I know many people who have not sur-
vived even after following everything recommended by their
physicians. Why don't patients participate in their own
treatment-related decision-making? They should. I believed
that the only way to survive was to be involved in the deci-
sion-making process regarding my treatment and not leav-
ing the decision in the hands of the physician. ...Although
my physician advised me to take an oral anti-cancer drug,
I refused to do so because I had never come across any dataBMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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suggesting that the drug was effective in treating the cancer
that I had. (Informant O)
Informant O expressed a strong belief in his own self-
determination and assertively appealed to his physician to
respect his preference, thus rejecting the oral chemothera-
peutic drugs that the physician had advised. In this cate-
gory, physicians are regarded as consultants with special
knowledge and skills that patients may utilize as impor-
tant sources of information. The decision-making process
adopted by Informant O can be described as an 'informed
approach', as proposed by Charles and colleagues, which
is characterised by the division of labour and preservation
of patient autonomy [7,8].
It is of interest that the informants in this category often
stated that they had gradually adopted this decision-mak-
ing style after experiencing confusion in the initial treat-
ment phase when they were forced to make decisions
without adequate knowledge, as in the case of Informant
I.
At the first hospital, nobody informed me about the nature
of my disease. Fortunately, at the next hospital, the physi-
cian provided me with all the necessary details regarding
Table 1: Socio-demographic backgrounds of the informants
Informant Gender Age Education Cancer type (primary) Time elapsed since diagnosis
A Female 57 Junior College Breast Cancer 5 yrs 3 mths
B Male 53 Graduate School Colon Cancer 10 mths
C Female 50 Junior College Lung Cancer 6 mths
D Female 58 High School Multiple Cancer aa
E Male 65 University Multiple Cancer bb
F Female 53 High School Colon Cancer 4 yrs
G Male 59 Unknown Liver Cancer 10 mths
H Male 66 University Lung Cancer 2 yrs 7 mths
I Male 53 University Lung Cancer 9 yrs 2 mths
J Male 60 University Colon Cancer 5 yrs 1 mth
K Female 61 High School Breast Cancer 8 yrs 5 mths
L Female 64 Career College Malignant Lymphoma 12 yrs
M Female 62 High School Breast Cancer 8 yrs
N Female 39 Graduate School Colon Cancer 1 yr 9 mths
O Male 59 University Pancreatic Cancer 5 yrs
P Female 42 University Gastric Cancer 1 yr 3 mths
Q Male 74 University Colon Cancer 16 yrs
R Male 58 University Esophageal Cancer 4 yrs
S Female 53 University Breast Cancer 4 yrs 9 mths
T Female 70 High School Uterine Cervical Cancer 13 yrs
U Female 60 High School Breast Cancer 9 yrs 6 mths
V Male 78 University Prostate Cancer 3 yrs 8 mths
W Female 57 High School Colon Cancer 3 yrs 1 mth
X Female 36 Unknown Colon Cancer 2 yrs 6 mths
a Gastric cancer (17 yrs), colon cancer (7 yrs 6 mths), chondrosarcoma (6 yrs)
b Colon cancer (14 yrs), lung cancer (7 yrs)
Patient participation in and overall satisfaction with the decision-making process Figure 1
Patient participation in and overall satisfaction with the decision-making process.
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my disease; however, he compelled me to make crucial deci-
sions that would ultimately kill or cure, despite my
extremely limited knowledge about the disease. I experi-
enced myriad problems and consequently changed the man-
ner in which I participated in the decision-making process.
A patient must, all by himself, determine whether the phy-
sician is correct or not. For this reason, I visited another
hospital for a second opinion. If you want to make your own
choice, you must have the necessary knowledge. Therefore,
I investigated, sought information, and asked questions. I
challenged myself to listen to people who had different ideas
with regard to my treatment and read the books that were
written by them. Subsequently, I chose the physician who
offered convincing answers to my questions. I refer to this
as participation in a decision-making process. ...Now, I
strongly believe that a patient and a physician should, as
equal partners, discuss the best treatment modality for the
patient and make a combined decision. Hence, I now adopt
this style of decision-making. (Informant I)
Informant I stated that he felt as though his physician had
shifted the responsibility of decision-making onto him,
despite his unpreparedness. As a result, he became more
assertive and approached his physician for explanations
regarding his disease and treatment options; in addition,
he gathered information from other resources to better
understand the physician's explanations. We can associate
Informant I's style to the 'shared approach' described by
Charles and colleagues, which is characterised by the dis-
cussion of treatment options by both the patient and phy-
sician as equal partners and the sharing of the
responsibility for decision-making [7,8].
Interestingly, informants who indicated that they played
an active role in the decision-making process did not nec-
essarily confirm whether, from their perspective, they
were the final decision makers (Informant O) or they
shared the responsibility of decision-making with their
physicians (Informant I). It is probable that informants
did not need to distinguish between the above 2 possibil-
ities because in either case, the patients had discussed
their treatment-related decisions with their physicians
and had expressed their opinions assertively, thus chal-
lenging the long-standing norm of Omakase in Japan.
Doctor selection
In the second category, the informants were eager to
gather information on the quality of hospitals and physi-
cians and wished to be informed as much as possible
about their treatment options; however, they still inten-
tionally left the final decision to the physician. Since the
act of decision-making was transferred to the physician,
this category can be referred to as 'paternalistic', consider-
ing the issue of making decisions per se; however, the
informants maintained a sense of self-determination and
showed a high level of satisfaction.
I attempted to gather as much information as possible on
the reputation of various physicians and hospitals. Moreo-
ver, I went to visit different physicians in person. ...Patients'
knowledge regarding medicine is miniscule as compared to
that of the physicians, which is, probably, a hundred times
greater. Given this information gap, it is futile for me to
attempt to determine whether radiotherapy and chemother-
apy or surgery is a better treatment option for me. Choosing
the right physician and asking him to decide is crucial.
(Informant Q)
We need to acquire accurate knowledge about our own
medical status and choose the most suitable physician
accordingly. I first asked my physician for his opinion and
then gathered considerable information from the media,
the Internet, etc. in order to find data that endorsed his
opinion. Since physicians possess detailed knowledge of
medicine and have considerable clinical experience, I was
unsure whether it was really necessary for me to make the
final decision. I trusted my physician. The ultimate purpose
was to cure my disease and not to personally make the final
decision. The fact that a treatment option is chosen by a
patient does not necessarily guarantee its effectiveness. If
one understands the treatment and agrees with it, it is irrel-
evant as to who makes the decision. Therefore, it is perhaps
reasonable to say that 'active participation' can be
rephrased as 'active agreement'. (Informant B)
In this category, the patients collected information to find
the right physician who would choose the appropriate
treatment option for them or to endorse the physician's
advice and understand it more thoroughly; however, it
was not to empower themselves in order to make the right
treatment-related decisions.
Wilfully entrusting the physician
In the third category, the informants entirely believed in
and trusted the physician's professionalism in general and
did not feel the need to evaluate the quality of each phy-
sician or to understand the content of the advice provided.
Therefore, they felt no desire to collect information
regarding a specific physician's reputation or the specific
treatments. In this category, the physician was the final
decision maker for her/his patient's treatment, and the
patient's role was to accept the physician's treatment deci-
sions without question. This category can be regarded as
Charles and colleagues' 'paternalistic approach', which is
characterised by giving the physician complete control
[7,8]. Given the current trend of patient-centred practice
in Japan, despite the negative connotation of the word
'paternalism', the informants expected the physicians toBMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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make decisions for them and were quite satisfied with the
overall decision-making process.
Basically, I trust physicians. In general, physicians, like
lawyers, have a strong philosophy of life, and therefore, I
respect them. My physician only informed me that 'there
would be no problems if you undergo surgery soon'. I had a
strong feeling that he was reliable, maybe, in part, due to
his personality. ...Since he said it would be fine, I did not
discuss treatment options with him any further. I trusted
him, and thereafter, I adopted the Omakase approach.
(Informant T)
Compelled decision-making
In the fourth category, the informants felt that they were
compelled to make a decision, even though they did not
have sufficient information or understanding regarding
their medical condition and treatment options. Although
they opted for a particular treatment from the myriad
options presented to them, they argued that the decision
was a forced act and that the responsibility of making the
decision was imposed on them by their physicians. The
informants' recollection of the situation was considerably
negative, and their overall satisfaction with the decision-
making process was extremely low. Informant I, who was
introduced in the 'patient as the active decision maker'
category, stated that he was also compelled to make a
decision during the initial treatment phase and recalled
the interaction with his physician with a sense of bitter-
ness.
At the time of making the decision regarding which treat-
ment to undertake, I had to choose one treatment option
and provide my physician with an answer. This was not
something that one could satisfactorily refer to as 'shared
decision-making'. I felt that I had to reach a conclusion
despite my lack of medical knowledge. Perhaps, by choosing
one treatment option from the many options that were pre-
sented to me, I did take active part in the decision-making
process; however, I do not consider it to be actual participa-
tion. It was merely the case of an ignorant person being
forced to make a decision. (Informant I)
In this case, Informant I stated that the problem was his
lack of medical knowledge. If, however, he was provided
with detailed information on his medical status and treat-
ment options and was given sufficient time to deliberate,
he might have been able to confidently decide his treat-
ment. Moreover, interviews revealed another kind of com-
pelled decision-making in which the patient was forced to
make the final decision against her/his will to leave the
decision to the physician. This is a typical example of the
disparity between patient preferences in decision-making
and their actual level of involvement.
I did not want to decide on my own; however, he (the phy-
sician) informed me that I was the decision maker. This
troubled me, and from then on, I could not sleep well. I wish
the physician had made the decision for me. I wanted the
physician to lead me in the right direction. I was completely
confused because the physician had imposed the responsibil-
ity of decision-making on me. (Informant R)
Surrendering decision-making
In the last category, the informants surrendered the con-
trol of decision-making to the physician and recalled the
entire process with a strong sense of resignation. This cat-
egory reflects the long-standing tradition of physicians'
domination in the decision-making process in Japan.
Although the informants actually wished to play a more
active role, they rejected the idea because they perceived a
marked difference in authority between themselves and
their physicians, and consequently, accepted the physi-
cian's advice without question. Therefore, when their phy-
sicians chose a certain treatment option for them without
providing them with the necessary knowledge on other
treatment options or the opportunity to express their pref-
erences, they assumed that they had no other choice but
to entrust their physicians to make the best decision for
them. This category can also be described as the 'paternal-
istic approach'; however, unlike the 'wilfully entrusting
the physician' category, the informants in this category
displayed dissatisfaction and a deep sense of resignation
with the overall decision-making process.
I cannot say that I was satisfied with the decision-making
process; however, I thought that I was not in a position to
assert myself and had to accept my physician's decision. As
a patient, I thought there was nothing I could offer, even
though I wanted to participate in the treatment-related
decision-making process. If the physician had provided me
information about the available treatment options, I think
I could have chosen one. The physician should have volun-
tarily explained to me what the best option was, providing
reasons for choosing it and explaining the advantages and
disadvantages of the other options. (Informant K)
Physicians often propose the idea of informed consent to
indicate that they respect the patients' will; however, in
fact, they are persuasive and assertive and enforce their
opinions on their patients. That is the way physicians are, I
think. (Informant D)
Although informant D accuses physicians in general of
imposing their opinions on the patients, she describes the
situation as 'that is the way physicians are' and does not
dare to inform her physician about her desire to partici-
pate more actively in the decision-making process.BMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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Discussion
This study aimed to explore the actual level of involve-
ment of Japanese cancer patients in treatment-related
decision-making as well as their overall satisfaction with
the decision-making process. The strength of this study is
in that we asked the patients about their actual experi-
ences; therefore, we could not only explore the actual level
of involvement of the patients in the decision-making
process but also reveal the situations in which the patients
were dissatisfied.
This study revealed that Japanese cancer patients' prefer-
ences regarding their role in treatment-related decision-
making varied widely from complete physician control to
complete patient control, which is similar to the preced-
ing studies conducted in the US, the UK, and Canada [9-
12,14,15]. Further, this study suggested that the correla-
tion between patient preferences regarding their involve-
ment in the decision-making process and their actual level
of involvement was a strong indicator of patient satisfac-
tion, which was independent of who made the final deci-
sion. Moreover, this finding is compatible with other
studies conducted in the US [12,14]. Patient involvement
in decision-making has been widely advocated in Japan,
presumably as a reaction to the historical paternalistic
patient-physician relationship [32]. However, it is prefer-
able that physicians be aware that merely allowing the
patients to decide their treatment option regardless of
their preferences may cause confusion rather than satisfac-
tion among patients. Instead, assessing each patient's pref-
erence regarding her/his role in the decision-making
process is extremely important in order to provide cus-
tomized, preference-sensitive care. It was also observed
that some physicians forced their patients to determine
their treatment without providing them with sufficient
treatment-related information. It appears that these physi-
cians attempted to involve the patients only in decision-
making and not in the preceding important steps of infor-
mation exchange and deliberation [8]. Therefore, it is
preferable for physicians to be informed that treatment-
related decision-making is the outcome of information
exchange and deliberation regarding the treatment
options, as proposed by Charles and colleagues [8].
Another interesting finding of this study is the 3 distinct
categories in which the patients allowed the physician to
make the final decision: 'wilfully entrusting the physi-
cian', 'surrendering decision-making', and 'doctor selec-
tion'. 'Wilfully entrusting the physician' and 'doctor
selection' can be regarded as the 'active Omakase' model,
and 'surrendering decision-making' can be considered to
be the 'passive Omakase' model. These models have been
described in detail by Slingsby, who conducted interviews
with Japanese psychiatrists and analysed, from the psychi-
atrists' perspective, the patient-physician relationship in
the treatment of minor mood disorders in Japan [18]. It
would be reasonable to state that from the perspective of
the cancer patients, the 'wilfully entrusting the physician'
and 'surrendering decision-making' categories in this
study endorse the presence of 2 kinds of Omakase styles.
The third category, 'doctor selection', is also of interest.
This category is different from the previous 2 categories in
that the patients are eager to gather information on the
quality and reputation of hospitals and physicians and
wish to be informed as much as possible regarding treat-
ment options. This may be a category characteristic to a
country like Japan where all people are covered by the
National Health Insurance System and are allowed to
choose any physician of their choice [33]. In such a
healthcare system, patient participation begins at the stage
when the patient chooses a physician for herself/himself,
and hence, patients can maintain a sense of autonomy
and self-determination even if they do not decide their
treatments themselves. Hashimoto and Fukuhara investi-
gated the Japanese general population and reported that
people's preferences with respect to acquiring information
was not associated with their preference regarding their
role in the decision-making process, particularly among
individuals who believed that their health was dependent
on other influences such as physicians, family, and friends
[34]. They speculated that such individuals may use the
information for purposes other than rational decision-
making, such as anticipating what is going to happen
next. The 'doctor selection' category is an example of the
manner in which information is used by patients for pur-
poses other than rational decision-making.
This study has several limitations which should also be
acknowledged. The first is the recall bias which was a
result of the interviews being conducted retrospectively;
thus, the findings might have been influenced by a
number of factors, including the time elapsed since the
patient underwent treatment and the patients' current
health status. Second, the fact that most of the informants
of this study reside in the Tokyo metropolitan area
reduces the generalizability of the findings of this study.
We can speculate that if the patients had been residing in
a rural area, where the access to both medical facilities and
healthcare information is limited and the patient-physi-
cian relationship is under the influence of more conserva-
tive socio-cultural norms, their decision-making
categories might have differed from those described in
this study. Third, all informants were not in the terminal
stage of the disease at the time of the diagnosis and thus,
had a high chance of survival for at least a certain period
of time. If the respondents were in the advanced stage of
cancer at the time of diagnosis, it might have influenced
their preference regarding their role in the decision-mak-
ing process. Furthermore, during the interviews, we did
not necessarily explore the number of treatment optionsBMC Public Health 2008, 8:77 http://www.biomedcentral.com/1471-2458/8/77
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available to each informant. Since the level of involve-
ment of a patient will depend on the number of options
available to her/him, we should have enquired about
available information in more detail and considered it in
the analysis.
Despite the above-mentioned limitations, we still believe
that this study can offer several implications to increase
patient satisfaction with regard to the decision-making
process in the oncology setting in Japan. First and most
importantly, we need to discuss the measures to more
accurately understand each patient's preference regarding
her/him roles in the decision-making process. Bruera and
colleagues proposed that patient preferences should be
assessed on a prospective basis by directly asking the
patient rather than assuming that the existing level of
communication will allow the physician to predict a strat-
egy [35]. This approach toward prospectively and directly
assessing patient preferences is important as evident from
the results of a preceding study, which suggest that physi-
cians, even those highly trained in communication skills,
are not equipped to predict patient preferences regarding
their role in decision-making [35]. Second, patients
should be provided with (1) detailed information on the
available treatment options and (2) sufficient time to
deliberate on the options before being required to make a
decision. Moreover, physicians should be aware that,
merely attempting to involve patients into treatment-
related decision-making without adequate information
exchange and deliberation on the options can result in
dissatisfaction on the part of the patients. Further, physi-
cians should be advised on how to effectively utilize the
available educational material to increase their patients'
understanding of the disease and treatment options. Since
around 2004, many evidence-based, clinical practice
guidelines have been published in Japan, and some of the
guidelines which originally targeted physicians have been
re-edited with the help of patient groups and published
for use by patients. In addition, we observed an increase
in the number of reliable online cancer information serv-
ices provided by the government, healthcare profession-
als, and patient groups [36]. These trends have facilitated
information exchange and discussion between patients
and physicians, because reliable cancer information serv-
ices such as those provided by the American Cancer Soci-
ety or National Cancer Institute in the US had long been
lacking in Japan. The interviews for the current research
were conducted in 2001, when these changes were still in
their nascent stage. Patients who were more recently diag-
nosed might have been able to collect reliable informa-
tion more efficiently than the informants of the current
research were able to. Third, we need to inform the
patients under the 'surrendering decision-making' cate-
gory that they should express their preferences regarding
their role in the decision-making process more explicitly.
For this purpose, we also need to explore the reasons why
such patients have a sense of resignation, in contrast to
those who become more assertive in expressing their pref-
erences after unsatisfactory experiences related to deci-
sion-making.
Conclusion
This study revealed that (1) a marked variation exists in
the Japanese cancer patients' preferences regarding their
role in decision-making and (2) the main factor for
patient satisfaction was respecting the patients' prefer-
ences regarding their role in decision-making. We need to
create a better environment in hospitals and in society to
facilitate patients in expressing their preferences and find-
ing resources to support their decisions.
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